QIAGEN appointed Jonathan Pratt as CEO.

Every day, more than 500,000 customers around the world rely on QIAGEN solutions to extract meaning from genetic material quickly, confidently and accurately. Whether the goal is driving discovery, diagnosing disease or guiding treatment decisions, QIAGEN technologies help make the process reliable, fast and more impactful. These customers include young scientists, pharma R&D teams, clinical labs and more than 35 Nobel Prize winners, all choosing QIAGEN to help advance science and improve outcomes. QIAGEN is not just a supplier of kits and instruments. We are a partner in progress, backed by a deep commitment to science and better healthcare. In a world where the stakes continue to rise and the questions grow more complex, QIAGEN exists to accelerate the breakthroughs science and society urgently need, by advancing science and improving healthcare. This is how we make improvements in life possible. Discover more at ➡️ http://www.qiagen.com